Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$88K Sell
1,266
-86
-6% -$6.5K 0.03% 204
2023
Q2
$109K Hold
1,352
0.03% 199
2023
Q1
$109K Sell
1,352
-57
-4% -$4.59K 0.03% 200
2022
Q4
$105K Hold
1,409
0.04% 208
2022
Q3
$91K Hold
1,409
0.03% 205
2022
Q2
$98K Buy
1,409
+1,379
+4,597% +$102K 0.03% 211
2022
Q1
$2K Hold
30
﹤0.01% 558
2021
Q4
$2K Buy
+30
New +$2.21K ﹤0.01% 590
2021
Q3
Sell
-30
Closed -$2K 336
2021
Q2
$2K Sell
30
-823
-96% -$55K ﹤0.01% 562
2021
Q1
$63K Buy
+853
New +$64.8K 0.03% 244

Other funds holding HOLX

KB Financial Partners's HOLX Position: Q3 2023 in Review

KB Financial Partners reduced its Hologic (HOLX) stake by 6.4% in Q3 2023, selling an estimated $6.5K and leaving 1,266 shares worth $88K. The position accounts for 0.03% of the portfolio, ranked #204.

KB Financial Partners first reported a position in HOLX in Q1 2021 and has held it in 10 quarters since. The position peaked at $109K in Q2 2023. 692 funds tracked by Wall St. Rank hold HOLX as of Q3 2023.

  • KB Financial Partners held 1,266 shares of Hologic worth $88K as of Q3 2023.
  • KB Financial Partners sold 86 Hologic shares in Q3 2023, an estimated $6.5K.
  • Hologic made up 0.03% of KB Financial Partners's portfolio in Q3 2023, its #204 holding.
  • KB Financial Partners first reported a position in Hologic in Q1 2021 and has held it in 10 quarters since.
  • KB Financial Partners's Hologic position peaked at $109K in Q2 2023.
  • 692 funds tracked by Wall St. Rank held Hologic as of Q3 2023.

Based on KB Financial Partners's 13F filing for Q3 2023, filed 15 Nov 2023.